Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis

BACKGROUND: Shexiang Baoxin Pill (SBP) is one of the most commonly used traditional Chinese patent medicines for cardiovascular diseases. This systematic review was designed to provide rigorous therapeutic efficacy and safety evidence on the use of SBP combined with trimetazidine in elderly patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Jianxia, Ma, Xiao, Zhang, Lu, Lu, Xiaohua, Yang, Yuxue, Wang, Jian, Zhao, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320128/
https://www.ncbi.nlm.nih.gov/pubmed/30572460
http://dx.doi.org/10.1097/MD.0000000000013580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320128/
https://www.ncbi.nlm.nih.gov/pubmed/30572460
http://dx.doi.org/10.1097/MD.0000000000013580

Ejemplares similares